25 XP   0   0   10

Pulse Biosciences Inc
Buy, Hold or Sell?

Let's analyse Pulse Biosciences Inc together

PenkeI guess you are interested in Pulse Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pulse Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pulse Biosciences Inc

I send you an email if I find something interesting about Pulse Biosciences Inc.

Quick analysis of Pulse Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Pulse Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
$0.80
Expected worth in 1 year
$4.18
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$3.38
Return On Investment
43.2%

For what price can you sell your share?

Current Price per Share
$7.82
Expected price per share
$4.7 - $7.79
How sure are you?
50%

1. Valuation of Pulse Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$7.82

Intrinsic Value Per Share

$-7.21 - $-5.64

Total Value Per Share

$-6.40 - $-4.84

2. Growth of Pulse Biosciences Inc (5 min.)




Is Pulse Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$44.3m-$2.2m$46.6m105.1%

How much money is Pulse Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$42.2m-$58.9m$16.7m39.7%
Net Profit Margin469,000.0%-8,421.9%--

How much money comes from the company's main activities?

3. Financial Health of Pulse Biosciences Inc (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#123 / 169

Most Revenue
#169 / 169

Most Profit
#147 / 169

Most Efficient
#106 / 169

What can you expect buying and holding a share of Pulse Biosciences Inc? (5 min.)

Welcome investor! Pulse Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Pulse Biosciences Inc.

What can you expect buying and holding a share of Pulse Biosciences Inc?

First you should know what it really means to hold a share of Pulse Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Pulse Biosciences Inc is $7.82. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pulse Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pulse Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.80. Based on the TTM, the Book Value Change Per Share is $0.84 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.69 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pulse Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.76-9.8%-0.76-9.8%-1.07-13.7%-0.95-12.1%-0.61-7.8%
Usd Book Value Change Per Share0.8410.8%0.8410.8%-0.69-8.8%-0.08-1.0%0.081.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.1%0.000.0%
Usd Total Gains Per Share0.8410.8%0.8410.8%-0.69-8.8%-0.07-1.0%0.081.1%
Usd Price Per Share12.24-12.24-2.77-13.42-10.87-
Price to Earnings Ratio-16.01--16.01--2.59--14.73--17.92-
Price-to-Total Gains Ratio14.50-14.50--4.03--23.72-0.79-
Price to Book Ratio15.24-15.24--68.05-10.35-10.38-
Price-to-Total Gains Ratio14.50-14.50--4.03--23.72-0.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.82
Number of shares127
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.84-0.08
Usd Total Gains Per Share0.84-0.07
Gains per Quarter (127 shares)107.18-9.45
Gains per Year (127 shares)428.73-37.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104294193-40-48
208578485-81-86
30128612778-121-124
401715170611-162-162
502144213513-202-200
602572256416-243-238
703001299318-283-276
803430342221-323-314
903859385124-364-352
1004287428026-404-390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%6.04.00.060.0%6.04.00.060.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%2.00.03.040.0%2.00.08.020.0%2.00.08.020.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%6.04.00.060.0%6.04.00.060.0%

Fundamentals of Pulse Biosciences Inc

About Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Fundamental data was last updated by Penke on 2024-05-04 00:55:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pulse Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pulse Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 469,000.0% means that $4,690.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pulse Biosciences Inc:

  • The MRQ is 469,000.0%. The company is making a huge profit. +2
  • The TTM is 469,000.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ469,000.0%TTM469,000.0%0.0%
TTM469,000.0%YOY-8,421.9%+477,421.9%
TTM469,000.0%5Y82,499.0%+386,501.0%
5Y82,499.0%10Y38,814.7%+43,684.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ469,000.0%6.1%+468,993.9%
TTM469,000.0%6.5%+468,993.5%
YOY-8,421.9%8.0%-8,429.9%
5Y82,499.0%7.3%+82,491.7%
10Y38,814.7%6.8%+38,807.9%
1.1.2. Return on Assets

Shows how efficient Pulse Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • -69.4% Return on Assets means that Pulse Biosciences Inc generated $-0.69 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pulse Biosciences Inc:

  • The MRQ is -69.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -69.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-69.4%TTM-69.4%0.0%
TTM-69.4%YOY-75.7%+6.3%
TTM-69.4%5Y-98.3%+28.9%
5Y-98.3%10Y-65.5%-32.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-69.4%1.3%-70.7%
TTM-69.4%1.4%-70.8%
YOY-75.7%1.9%-77.6%
5Y-98.3%2.2%-100.5%
10Y-65.5%2.1%-67.6%
1.1.3. Return on Equity

Shows how efficient Pulse Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • -95.2% Return on Equity means Pulse Biosciences Inc generated $-0.95 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pulse Biosciences Inc:

  • The MRQ is -95.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -95.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-95.2%TTM-95.2%0.0%
TTM-95.2%YOY--95.2%
TTM-95.2%5Y-127.8%+32.6%
5Y-127.8%10Y-81.2%-46.6%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-95.2%2.5%-97.7%
TTM-95.2%2.7%-97.9%
YOY-3.7%-3.7%
5Y-127.8%3.8%-131.6%
10Y-81.2%3.8%-85.0%

1.2. Operating Efficiency of Pulse Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pulse Biosciences Inc is operating .

  • Measures how much profit Pulse Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 484,155.6% means the company generated $4,841.56  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pulse Biosciences Inc:

  • The MRQ is 484,155.6%. The company is operating very efficient. +2
  • The TTM is 484,155.6%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ484,155.6%TTM484,155.6%0.0%
TTM484,155.6%YOY-8,293.9%+492,449.4%
TTM484,155.6%5Y85,517.8%+398,637.8%
5Y85,517.8%10Y40,304.1%+45,213.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ484,155.6%7.9%+484,147.7%
TTM484,155.6%7.6%+484,148.0%
YOY-8,293.9%10.9%-8,304.8%
5Y85,517.8%10.1%+85,507.7%
10Y40,304.1%10.5%+40,293.6%
1.2.2. Operating Ratio

Measures how efficient Pulse Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of -4,841.56 means that the operating costs are $-4,841.56 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pulse Biosciences Inc:

  • The MRQ is -4,841.556.
  • The TTM is -4,841.556.
Trends
Current periodCompared to+/- 
MRQ-4,841.556TTM-4,841.5560.000
TTM-4,841.556YOY83.939-4,925.494
TTM-4,841.5565Y-853.611-3,987.944
5Y-853.61110Y-401.010-452.601
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-4,841.5561.153-4,842.709
TTM-4,841.5561.175-4,842.731
YOY83.9391.112+82.827
5Y-853.6111.101-854.712
10Y-401.0101.066-402.076

1.3. Liquidity of Pulse Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pulse Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 6.76 means the company has $6.76 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pulse Biosciences Inc:

  • The MRQ is 6.757. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.757. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.757TTM6.7570.000
TTM6.757YOY10.391-3.633
TTM6.7575Y6.063+0.694
5Y6.06310Y13.224-7.161
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7572.310+4.447
TTM6.7572.358+4.399
YOY10.3912.614+7.777
5Y6.0632.649+3.414
10Y13.2242.630+10.594
1.3.2. Quick Ratio

Measures if Pulse Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 6.61 means the company can pay off $6.61 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pulse Biosciences Inc:

  • The MRQ is 6.614. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.614. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.614TTM6.6140.000
TTM6.614YOY10.222-3.608
TTM6.6145Y6.760-0.147
5Y6.76010Y18.847-12.086
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6141.119+5.495
TTM6.6141.148+5.466
YOY10.2221.306+8.916
5Y6.7601.433+5.327
10Y18.8471.544+17.303

1.4. Solvency of Pulse Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pulse Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pulse Biosciences Inc to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.27 means that Pulse Biosciences Inc assets are financed with 27.0% credit (debt) and the remaining percentage (100% - 27.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pulse Biosciences Inc:

  • The MRQ is 0.270. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.270. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.270TTM0.2700.000
TTM0.270YOY1.029-0.758
TTM0.2705Y0.471-0.200
5Y0.47110Y0.268+0.203
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2700.351-0.081
TTM0.2700.357-0.087
YOY1.0290.349+0.680
5Y0.4710.359+0.112
10Y0.2680.369-0.101
1.4.2. Debt to Equity Ratio

Measures if Pulse Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 37.1% means that company has $0.37 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pulse Biosciences Inc:

  • The MRQ is 0.371. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.371. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.371TTM0.3710.000
TTM0.371YOY-+0.371
TTM0.3715Y0.412-0.041
5Y0.41210Y0.241+0.171
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3710.541-0.170
TTM0.3710.557-0.186
YOY-0.545-0.545
5Y0.4120.640-0.228
10Y0.2410.669-0.428

2. Market Valuation of Pulse Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pulse Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -16.01 means the investor is paying $-16.01 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pulse Biosciences Inc:

  • The EOD is -10.231. Based on the earnings, the company is expensive. -2
  • The MRQ is -16.014. Based on the earnings, the company is expensive. -2
  • The TTM is -16.014. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.231MRQ-16.014+5.783
MRQ-16.014TTM-16.0140.000
TTM-16.014YOY-2.595-13.419
TTM-16.0145Y-14.731-1.283
5Y-14.73110Y-17.920+3.189
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-10.23114.193-24.424
MRQ-16.01415.710-31.724
TTM-16.01416.048-32.062
YOY-2.59520.916-23.511
5Y-14.73120.583-35.314
10Y-17.92022.810-40.730
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pulse Biosciences Inc:

  • The EOD is -13.023. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -20.384. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -20.384. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.023MRQ-20.384+7.361
MRQ-20.384TTM-20.3840.000
TTM-20.384YOY-3.226-17.157
TTM-20.3845Y-19.339-1.045
5Y-19.33910Y-26.268+6.929
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-13.0237.306-20.329
MRQ-20.3847.992-28.376
TTM-20.3840.716-21.100
YOY-3.2263.549-6.775
5Y-19.3397.859-27.198
10Y-26.2680.247-26.515
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pulse Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 15.24 means the investor is paying $15.24 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pulse Biosciences Inc:

  • The EOD is 9.735. Based on the equity, the company is overpriced. -1
  • The MRQ is 15.238. Based on the equity, the company is expensive. -2
  • The TTM is 15.238. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD9.735MRQ15.238-5.503
MRQ15.238TTM15.2380.000
TTM15.238YOY-68.049+83.287
TTM15.2385Y10.351+4.887
5Y10.35110Y10.382-0.031
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD9.7352.404+7.331
MRQ15.2382.753+12.485
TTM15.2382.663+12.575
YOY-68.0493.303-71.352
5Y10.3513.958+6.393
10Y10.3824.277+6.105
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Pulse Biosciences Inc.

3.1. Institutions holding Pulse Biosciences Inc

Institutions are holding 8.133% of the shares of Pulse Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc1.94580.0003107173610530710.8965
2023-12-31Bank of America Corp1.45490.00180134193711.1833
2023-12-31Vanguard Group Inc1.19460.000265798531651992.6941
2023-12-31Geode Capital Management, LLC0.68860.0005379259251747.1096
2023-12-31State Street Corporation0.56190.0002309520252848.8954
2023-12-31Hovey Youngman Associates Inc0.47130.4029259620-15140-5.5103
2023-12-31Northern Trust Corp0.33340.000418366548772.7278
2023-12-31Spotlight Asset Group, Inc.0.13090.26357209000
2023-12-31Bank of New York Mellon Corp0.08370.000146129-5826-11.2136
2023-12-31Morgan Stanley - Brokerage Accounts0.08250.0001454381904472.1528
2023-12-31Advisor Group Holdings, Inc.0.08020.00144195-15212-25.6064
2023-12-31Charles Schwab Investment Management Inc0.07930.00014369500
2023-12-31SIMPLEX TRADING, LLC0.06230.000334293342930
2023-12-31Westside Investment Management, Inc.0.0620.10734175-24583-41.8377
2023-12-31JANE STREET GROUP, LLC0.0610.000133578335780
2023-12-31CWM Advisors, LLC0.05690.042231319313190
2023-12-31Susquehanna International Group, LLP0.050.000127535275350
2023-12-31TIAA Trust National Association0.04960.00112729800
2023-12-31Marshall Wace Asset Management Ltd0.04820.000626532265320
2023-12-31Nuveen Asset Management, LLC0.04790.000126372360715.8445
Total 7.5450.82184155775+601679+14.5%

3.2. Funds holding Pulse Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv0.86740.000347901700
2024-03-28iShares Russell 2000 ETF0.71320.00523938551890.048
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.46580.002525724400
2024-01-31Fidelity Small Cap Index0.29670.005916384124601.5243
2024-03-28iShares Russell 2000 Value ETF0.20590.0079113716-72-0.0633
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.19230.002510620030002.907
2024-02-29Fidelity Extended Market Index0.17720.002597878-474-0.4819
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.10680.00535900000
2024-02-29Vanguard Russell 2000 ETF0.10530.0065813246288.6498
2023-12-31NT R2000 Index Fund - NL0.07860.0073434052080.4815
2024-02-29Fidelity Nasdaq Composite Index0.06690.00243694000
2024-02-29Schwab Small Cap Index0.06690.00623692200
2023-09-30BlackRock Extended Mkt Composite0.06610.001365062830.7813
2024-03-28iShares Russell 2000 Growth ETF0.06540.002736092-42-0.1162
2024-03-28iShares Micro-Cap ETF0.06330.03313493800
2023-12-31NT R2000 Index Fund - DC - NL - 20.06190.007334182320.0937
2023-12-31NT R2000 Value Index Fund - NL0.05710.0102315261470.4685
2024-03-31BlackRock Extended Equity Market K0.05690.001931444110.035
2024-02-29Fidelity Total Market Index0.05420.00032991500
2024-02-29iShares Russell 2000 Small-Cap Idx Instl0.05410.00642986000
Total 3.8220.11692110613+10370+0.5%

3.3. Insider Transactions

Insiders are holding 70.381% of the shares of Pulse Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-11Robert W DugganBUY901189.36
2023-12-08Robert W DugganBUY1166569.54
2023-12-06Robert W DugganBUY828139.06
2023-12-04Robert W DugganBUY2700010.38
2023-11-30Robert W DugganBUY1529449.06
2023-11-28Robert W DugganBUY1243978.98
2023-11-17Robert W DugganBUY202416.1
2023-11-16Kevin Patrick DanahyBUY53936.52
2023-11-15Mitchell E LevinsonBUY42615.87
2023-05-09Robert W DugganBUY100229376.51

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Pulse Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8440.8440%-0.687+181%-0.080+109%0.080+951%
Book Value Per Share--0.8030.8030%-0.041+105%0.476+69%0.541+48%
Current Ratio--6.7576.7570%10.391-35%6.063+11%13.224-49%
Debt To Asset Ratio--0.2700.2700%1.029-74%0.471-43%0.268+1%
Debt To Equity Ratio--0.3710.3710%-+100%0.412-10%0.241+54%
Dividend Per Share----0%-0%0.005-100%0.003-100%
Eps---0.764-0.7640%-1.067+40%-0.948+24%-0.611-20%
Free Cash Flow Per Share---0.600-0.6000%-0.859+43%-0.745+24%-0.462-23%
Free Cash Flow To Equity Per Share---0.304-0.3040%0.589-152%-0.057-81%0.126-341%
Gross Profit Margin--1.0291.0290%1.204-15%1.148-10%1.074-4%
Intrinsic Value_10Y_max---5.639--------
Intrinsic Value_10Y_min---7.206--------
Intrinsic Value_1Y_max---0.708--------
Intrinsic Value_1Y_min---0.800--------
Intrinsic Value_3Y_max---2.018--------
Intrinsic Value_3Y_min---2.351--------
Intrinsic Value_5Y_max---3.197--------
Intrinsic Value_5Y_min---3.831--------
Market Cap431861846.000-57%675957672.000675957672.0000%152974081.000+342%741013075.400-9%600022884.500+13%
Net Profit Margin--4690.0004690.0000%-84.219+102%824.990+468%388.147+1108%
Operating Margin--4841.5564841.5560%-82.939+102%855.178+466%403.041+1101%
Operating Ratio---4841.556-4841.5560%83.939-5868%-853.611-82%-401.010-92%
Pb Ratio9.735-57%15.23815.2380%-68.049+547%10.351+47%10.382+47%
Pe Ratio-10.231+36%-16.014-16.0140%-2.595-84%-14.731-8%-17.920+12%
Price Per Share7.820-57%12.24012.2400%2.770+342%13.418-9%10.865+13%
Price To Free Cash Flow Ratio-13.023+36%-20.384-20.3840%-3.226-84%-19.339-5%-26.268+29%
Price To Total Gains Ratio9.266-57%14.50314.5030%-4.032+128%-23.719+264%0.794+1727%
Quick Ratio--6.6146.6140%10.222-35%6.760-2%18.847-65%
Return On Assets---0.694-0.6940%-0.757+9%-0.983+42%-0.655-6%
Return On Equity---0.952-0.9520%--100%-1.278+34%-0.812-15%
Total Gains Per Share--0.8440.8440%-0.687+181%-0.074+109%0.083+918%
Usd Book Value--44360001.00044360001.0000%-2248000.000+105%26286600.200+69%29879975.200+48%
Usd Book Value Change Per Share--0.8440.8440%-0.687+181%-0.080+109%0.080+951%
Usd Book Value Per Share--0.8030.8030%-0.041+105%0.476+69%0.541+48%
Usd Dividend Per Share----0%-0%0.005-100%0.003-100%
Usd Eps---0.764-0.7640%-1.067+40%-0.948+24%-0.611-20%
Usd Free Cash Flow---33161999.000-33161999.0000%-47414000.000+43%-41141799.800+24%-25528879.700-23%
Usd Free Cash Flow Per Share---0.600-0.6000%-0.859+43%-0.745+24%-0.462-23%
Usd Free Cash Flow To Equity Per Share---0.304-0.3040%0.589-152%-0.057-81%0.126-341%
Usd Market Cap431861846.000-57%675957672.000675957672.0000%152974081.000+342%741013075.400-9%600022884.500+13%
Usd Price Per Share7.820-57%12.24012.2400%2.770+342%13.418-9%10.865+13%
Usd Profit---42210000.000-42210000.0000%-58953000.000+40%-52009600.000+23%-33596414.000-20%
Usd Revenue---9000.000-9000.0000%700000.000-101%444600.000-102%253800.000-104%
Usd Total Gains Per Share--0.8440.8440%-0.687+181%-0.074+109%0.083+918%
 EOD+2 -6MRQTTM+0 -0YOY+24 -105Y+25 -1110Y+14 -22

4.2. Fundamental Score

Let's check the fundamental score of Pulse Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.231
Price to Book Ratio (EOD)Between0-19.735
Net Profit Margin (MRQ)Greater than04,690.000
Operating Margin (MRQ)Greater than04,841.556
Quick Ratio (MRQ)Greater than16.614
Current Ratio (MRQ)Greater than16.757
Debt to Asset Ratio (MRQ)Less than10.270
Debt to Equity Ratio (MRQ)Less than10.371
Return on Equity (MRQ)Greater than0.15-0.952
Return on Assets (MRQ)Greater than0.05-0.694
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Pulse Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose8.090
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets60,804
Total Liabilities16,444
Total Stockholder Equity44,360
 As reported
Total Liabilities 16,444
Total Stockholder Equity+ 44,360
Total Assets = 60,804

Assets

Total Assets60,804
Total Current Assets45,328
Long-term Assets15,476
Total Current Assets
Cash And Cash Equivalents 44,365
Other Current Assets 963
Total Current Assets  (as reported)45,328
Total Current Assets  (calculated)45,328
+/-0
Long-term Assets
Property Plant Equipment 8,784
Goodwill 2,791
Intangible Assets 1,886
Long-term Assets Other 365
Long-term Assets  (as reported)15,476
Long-term Assets  (calculated)13,826
+/- 1,650

Liabilities & Shareholders' Equity

Total Current Liabilities6,708
Long-term Liabilities9,736
Total Stockholder Equity44,360
Total Current Liabilities
Short-term Debt 1,058
Accounts payable 1,836
Other Current Liabilities 3,814
Total Current Liabilities  (as reported)6,708
Total Current Liabilities  (calculated)6,708
+/-0
Long-term Liabilities
Capital Lease Obligations 9,144
Long-term Liabilities  (as reported)9,736
Long-term Liabilities  (calculated)9,144
+/- 592
Total Stockholder Equity
Common Stock55
Retained Earnings -336,915
Other Stockholders Equity 381,220
Total Stockholder Equity (as reported)44,360
Total Stockholder Equity (calculated)44,360
+/-0
Other
Capital Stock55
Cash and Short Term Investments 44,365
Common Stock Shares Outstanding 48,038
Liabilities and Stockholders Equity 60,804
Net Debt -35,221
Net Invested Capital 44,360
Net Working Capital 38,620
Property Plant and Equipment Gross 12,260
Short Long Term Debt Total 9,144



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
17,896
14,325
26,314
49,821
70,640
41,915
41,293
54,249
77,877
60,804
60,80477,87754,24941,29341,91570,64049,82126,31414,32517,896
   > Total Current Assets 
7,031
3,997
16,663
38,481
60,362
26,403
22,339
36,630
62,147
45,328
45,32862,14736,63022,33926,40360,36238,48116,6633,9977,031
       Cash And Cash Equivalents 
7,009
3,606
2,089
3,386
51,103
6,899
12,463
28,614
61,139
44,365
44,36561,13928,61412,4636,89951,1033,3862,0893,6067,009
       Short-term Investments 
0
14,306
14,306
34,683
8,480
18,499
8,012
0
0
0
0008,01218,4998,48034,68314,30614,3060
       Net Receivables 
0
0
0
0
0
0
0
61
0
0
00610000000
       Other Current Assets 
22
44
268
412
779
1,005
1,864
2,131
1,008
963
9631,0082,1311,8641,0057794122684422
   > Long-term Assets 
10,865
10,328
9,651
11,340
10,278
15,512
18,954
17,619
15,730
15,476
15,47615,73017,61918,95415,51210,27811,3409,65110,32810,865
       Property Plant Equipment 
190
329
317
2,570
2,173
7,680
11,916
11,247
10,023
8,784
8,78410,02311,24711,9167,6802,1732,570317329190
       Goodwill 
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,7912,7912,7912,7912,7912,7912,7912,7912,7912,791
       Intangible Assets 
7,874
7,208
6,543
5,878
5,213
4,547
3,882
3,216
2,551
1,886
1,8862,5513,2163,8824,5475,2135,8786,5437,2087,874
       Long-term Assets Other 
10
0
0
101
101
494
365
365
365
365
3653653653654941011010010
> Total Liabilities 
1,821
660
1,016
3,826
4,306
11,178
18,399
18,559
80,125
16,444
16,44480,12518,55918,39911,1784,3063,8261,0166601,821
   > Total Current Liabilities 
165
660
1,016
2,213
3,108
4,459
7,585
8,519
5,981
6,708
6,7085,9818,5197,5854,4593,1082,2131,016660165
       Short-term Debt 
0
0
0
0
0
0
542
1,210
1,813
1,058
1,0581,8131,210542000000
       Short Long Term Debt 
0
0
0
0
0
0
0
436
917
0
09174360000000
       Accounts payable 
33
262
265
782
1,272
1,963
1,717
2,904
1,573
1,836
1,8361,5732,9041,7171,9631,27278226526233
       Other Current Liabilities 
92
398
751
1,431
1,836
2,496
5,326
4,389
2,595
3,814
3,8142,5954,3895,3262,4961,8361,43175139892
   > Long-term Liabilities 
1,657
262
265
1,613
1,198
6,719
10,814
10,040
74,144
9,736
9,73674,14410,04010,8146,7191,1981,6132652621,657
       Other Liabilities 
1,657
0
0
1,613
1,198
0
0
0
0
0
000001,1981,613001,657
       Deferred Long Term Liability 
0
0
0
1,613
1,198
0
0
0
0
0
000001,1981,613000
> Total Stockholder Equity
16,074
13,665
25,298
45,995
66,334
30,737
22,894
35,690
-2,248
44,360
44,360-2,24835,69022,89430,73766,33445,99525,29813,66516,074
   Common Stock
8
8
13
84,219
142,053
21
25
29
37
55
5537292521142,05384,2191388
   Retained Earnings -336,915-294,705-236,200-172,540-122,689-75,718-38,173-12,606-3,088-277
   Capital Surplus 
0
16,746
37,898
84,202
142,032
153,401
195,410
0
0
0
000195,410153,401142,03284,20237,89816,7460
   Treasury Stock0000000000
   Other Stockholders Equity 
16,343
16,746
37,898
84,202
142,032
153,401
195,410
271,861
292,420
381,220
381,220292,420271,861195,410153,401142,03284,20237,89816,74616,343



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue-9
Cost of Revenue-1,207
Gross Profit-1,207-1,216
 
Operating Income (+$)
Gross Profit-1,207
Operating Expense-42,367
Operating Income-43,574-43,574
 
Operating Expense (+$)
Research Development27,797
Selling General Administrative15,777
Selling And Marketing Expenses1,207
Operating Expense42,36744,781
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,364
Other Finance Cost-1,676
Net Interest Income312
 
Pretax Income (+$)
Operating Income-43,574
Net Interest Income312
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-42,210-44,938
EBIT - interestExpense = -44,938
-42,210
-40,846
Interest Expense1,364
Earnings Before Interest and Taxes (EBIT)-43,574-40,846
Earnings Before Interest and Taxes (EBITDA)-42,367
 
After tax Income (+$)
Income Before Tax-42,210
Tax Provision-0
Net Income From Continuing Ops-39,474-42,210
Net Income-42,210
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses43,574
Total Other Income/Expenses Net1,364-312
 

Technical Analysis of Pulse Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pulse Biosciences Inc. The general trend of Pulse Biosciences Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pulse Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pulse Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 7.77 < 7.79 < 7.79.

The bearish price targets are: 6.69 > 6.595 > 4.7.

Tweet this
Pulse Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pulse Biosciences Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pulse Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pulse Biosciences Inc.

Pulse Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartPulse Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pulse Biosciences Inc. The current adx is .

Pulse Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pulse Biosciences Inc.

Pulse Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pulse Biosciences Inc.

Pulse Biosciences Inc Daily Relative Strength Index (RSI) ChartPulse Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pulse Biosciences Inc.

Pulse Biosciences Inc Daily Stochastic Oscillator ChartPulse Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pulse Biosciences Inc.

Pulse Biosciences Inc Daily Commodity Channel Index (CCI) ChartPulse Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pulse Biosciences Inc.

Pulse Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartPulse Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pulse Biosciences Inc.

Pulse Biosciences Inc Daily Williams %R ChartPulse Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pulse Biosciences Inc.

Pulse Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pulse Biosciences Inc.

Pulse Biosciences Inc Daily Average True Range (ATR) ChartPulse Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pulse Biosciences Inc.

Pulse Biosciences Inc Daily On-Balance Volume (OBV) ChartPulse Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pulse Biosciences Inc.

Pulse Biosciences Inc Daily Money Flow Index (MFI) ChartPulse Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pulse Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-05-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Pulse Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pulse Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose8.090
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pulse Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Pulse Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pulse Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pulse Biosciences Inc

I send you an email if I find something interesting about Pulse Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Pulse Biosciences Inc.

Receive notifications about Pulse Biosciences Inc in your mailbox!